Publications by authors named "B Lemarchant"

Claim this Profile
P
Prevalence of hypogammaglobulinemia after non-anti-CD20 therapies and impact of switching to rituximab/ocrelizumab in multiple sclerosis.
Marine Perriguey, Camille Rigollet, Sean A Freeman, Lisa Graille-Avy, Jean-Christophe Lafontaine, Bruno Lemarchant

Neurotherapeutics· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Description of peripheral nervous system involvement in wild-type transthyretin amyloidosis: A clinical and electrophysiological study.
R Barriol, B Lemarchant, F Cassim, J-B Davion, L Defebvre

Rev Neurol (Paris)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extended-interval dosing of rituximab/ocrelizumab is associated with a reduced decrease in IgG levels in multiple sclerosis.
Camille Rigollet, Sean A Freeman, Marine Perriguey, Jan-Patrick Stellmann, Lisa Graille-Avy, Bruno Lemarchant

Neurotherapeutics· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-GAD Antibodies as an Etiology of Cerebral Cortical Encephalitis: 2 Case Reports.
Bruno Lemarchant, Cristina Birzu, Louis Cousyn, Stéphanie Rogeau, Delphine Leclercq

Eur J Neurol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune checkpoint inhibitors-associated cranial nerves involvement: a systematic literature review on 136 patients.
Samuel Pichon, Pauline Aigrain, Charlotte Lacombe, Bruno Lemarchant, Emmanuel Ledoult

J Neurol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis